BIIB
$BIIB
Biogen Inc.
Biotech company developing therapies for neurological diseases including Alzheimer's and MS.
Healthcare$183.41
+1.10 (+0.60%)
Day Range$181.68 - $185.44
Prev Close$182.31
Analyst Rating
Buy
20 Buy / 22 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
BIIB: Pipeline Progress Meets Valuation Check
Biogen ($BIIB) is advancing late‑stage programs and reporting encouraging rare disease data, yet shares trade near fair value with regulatory and execution risk. This report weighs catalysts against valuation and near‑term risks.
Mar 16, 2026